| |
Without remdesivir
|
With remdesivir
|
p valuea
|
|---|
|
n
|
%
|
n
|
%
|
|---|
|
Age
|
|
< 60
|
90
|
30.6
|
30
|
30.6
|
1.000
|
|
60 s
|
51
|
17.3
|
17
|
17.3
| |
|
≥ 70
|
153
|
52.0
|
51
|
52.0
| |
|
Gender
|
|
Male
|
210
|
71.7
|
67
|
68.4
|
0.524
|
|
Female
|
83
|
28.3
|
31
|
31.6
| |
|
Primary disease
|
|
Chronic glomerulonephritis
|
40
|
15.1
|
20
|
22.5
|
0.372
|
|
Diabetes mellitus
|
149
|
56.2
|
43
|
48.3
| |
|
Nephrosclerosis
|
39
|
14.7
|
12
|
13.5
| |
|
Others
|
37
|
14.0
|
14
|
15.7
| |
|
Duration of dialysis
|
|
< 1 year
|
37
|
12.9
|
14
|
14.4
|
0.754
|
|
1 to < 5 years
|
100
|
34.8
|
31
|
32.0
| |
|
5 to < 10 years
|
72
|
25.1
|
30
|
30.9
| |
|
10 to < 15 years
|
42
|
14.6
|
13
|
13.4
| |
|
≥ 15 years
|
36
|
12.5
|
9
|
9.3
| |
|
Complication
|
|
Hypertension
|
|
No
|
156
|
55.1
|
42
|
42.9
|
0.046
|
|
Yes
|
127
|
44.9
|
56
|
57.1
| |
|
Diabetes mellitus
|
|
No
|
124
|
43.5
|
46
|
46.9
|
0.558
|
|
Yes
|
161
|
56.5
|
52
|
53.1
| |
|
Cardiovascular disease
|
|
No
|
156
|
56.5
|
49
|
51.6
|
0.406
|
|
Yes
|
120
|
43.5
|
46
|
48.4
| |
|
Chronic respiratory disease
|
|
No
|
249
|
89.6
|
83
|
87.4
|
0.571
|
|
Yes
|
29
|
10.4
|
12
|
12.6
| |
|
Peripheral arterial disease
|
|
No
|
230
|
84.9
|
75
|
78.9
|
0.201
|
|
Yes
|
41
|
15.1
|
20
|
21.1
| |
|
Malignancy
|
|
No
|
234
|
84.2
|
83
|
87.4
|
0.509
|
|
Yes
|
44
|
15.8
|
12
|
12.6
| |
|
Number of complication
|
|
0
|
38
|
13.1
|
10
|
10.2
|
0.778
|
|
1
|
84
|
29.1
|
29
|
29.6
| |
|
≥ 2
|
167
|
57.8
|
59
|
60.2
| |
|
Oxygenation
|
|
No
|
69
|
23.5
|
23
|
23.5
|
1.000
|
|
Yes
|
159
|
54.1
|
53
|
54.1
| |
|
Ventilator or ECMO
|
66
|
22.4
|
22
|
22.4
| |
- ECMO extracorporeal membrane oxygenation
- aFisher’s exact test
